Search

Noble E. Jarrell

Examiner (ID: 13867, Phone: (571)272-9077 , Office: P/1625 )

Most Active Art Unit
1699
Art Unit(s)
1624, 1622, 1625, 1699, 1609, 1629
Total Applications
1459
Issued Applications
965
Pending Applications
172
Abandoned Applications
340

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8510552 [patent_doc_number] => 20120309961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'DIAZO BICYCLIC SMAC MIMETICS AND THE USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/557804 [patent_app_country] => US [patent_app_date] => 2012-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 37234 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13557804 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/557804
Diazo bicyclic Smac mimetics and the uses thereof Jul 24, 2012 Issued
Array ( [id] => 12489504 [patent_doc_number] => 09994444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-12 [patent_title] => Bridged polycyclic compound based compositions for the inhibition and amelioration of disease [patent_app_type] => utility [patent_app_number] => 13/548975 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 31943 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 555 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548975 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/548975
Bridged polycyclic compound based compositions for the inhibition and amelioration of disease Jul 12, 2012 Issued
Array ( [id] => 8944116 [patent_doc_number] => 08497295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Spiroindoline modulators of muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 13/546185 [patent_app_country] => US [patent_app_date] => 2012-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35853 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13546185 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/546185
Spiroindoline modulators of muscarinic receptors Jul 10, 2012 Issued
Array ( [id] => 8417719 [patent_doc_number] => 20120245218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'SURFACE MODIFIED NANOPARTICLES, METHODS OF THEIR PREPARATION, AND USES THEREOF FOR GENE AND DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/488940 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19989 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488940 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/488940
Surface modified nanoparticles, methods of their preparation, and uses thereof for gene and drug delivery Jun 4, 2012 Issued
Array ( [id] => 10876349 [patent_doc_number] => 08901135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-02 [patent_title] => 'Heterocyclic compounds and their uses' [patent_app_type] => utility [patent_app_number] => 13/468234 [patent_app_country] => US [patent_app_date] => 2012-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86502 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468234 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/468234
Heterocyclic compounds and their uses May 9, 2012 Issued
Array ( [id] => 8478015 [patent_doc_number] => 20120277421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'Metal Complexes of Tetraazamacrocycle Derivatives' [patent_app_type] => utility [patent_app_number] => 13/465223 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10890 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465223 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/465223
Metal complexes of tetraazamacrocycle derivatives May 6, 2012 Issued
Array ( [id] => 8324436 [patent_doc_number] => 20120196849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/443631 [patent_app_country] => US [patent_app_date] => 2012-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11458 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13443631 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/443631
COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS Apr 9, 2012 Abandoned
Array ( [id] => 8745538 [patent_doc_number] => 20130085255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'Process for Preparing Caprolactam and Polyamides Therefrom' [patent_app_type] => utility [patent_app_number] => 13/442306 [patent_app_country] => US [patent_app_date] => 2012-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19825 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442306 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/442306
Process for preparing caprolactam and polyamides therefrom Apr 8, 2012 Issued
Array ( [id] => 8442379 [patent_doc_number] => 20120258995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'New Indolinone Protein Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/441813 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3484 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441813 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/441813
Indolinone protein kinase inhibitors Apr 5, 2012 Issued
Array ( [id] => 8767030 [patent_doc_number] => 20130095066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'Compounds for the Treatment of Hepatitis C' [patent_app_type] => utility [patent_app_number] => 13/440003 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8494 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440003 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/440003
Compounds for the treatment of hepatitis C Apr 4, 2012 Issued
Array ( [id] => 8324448 [patent_doc_number] => 20120196855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'OXYGEN LINKED PYRIMIDINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/438989 [patent_app_country] => US [patent_app_date] => 2012-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33101 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438989 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/438989
Oxygen linked pyrimidine derivatives Apr 3, 2012 Issued
Array ( [id] => 8429706 [patent_doc_number] => 20120251581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Novel Compound and Methods for its Production' [patent_app_type] => utility [patent_app_number] => 13/433944 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22413 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433944 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/433944
Compound and methods for its production Mar 28, 2012 Issued
Array ( [id] => 8756026 [patent_doc_number] => 20130090331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASE' [patent_app_type] => utility [patent_app_number] => 13/429826 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22920 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13429826 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/429826
TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASE Mar 25, 2012 Abandoned
Array ( [id] => 8896735 [patent_doc_number] => 08476256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Diazonamide analogs' [patent_app_type] => utility [patent_app_number] => 13/430555 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26658 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430555 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/430555
Diazonamide analogs Mar 25, 2012 Issued
Array ( [id] => 8429687 [patent_doc_number] => 20120251560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'CONJUGATED LIPOMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/428695 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 39767 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428695 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/428695
Conjugated lipomers and uses thereof Mar 22, 2012 Issued
Array ( [id] => 8278553 [patent_doc_number] => 20120172422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Methods of Treatment Using a Prodrug of an Excitatory Amino Acid' [patent_app_type] => utility [patent_app_number] => 13/418613 [patent_app_country] => US [patent_app_date] => 2012-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48825 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418613 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/418613
Methods of Treatment Using a Prodrug of an Excitatory Amino Acid Mar 12, 2012 Abandoned
Array ( [id] => 9074607 [patent_doc_number] => 08552186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors' [patent_app_type] => utility [patent_app_number] => 13/413322 [patent_app_country] => US [patent_app_date] => 2012-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 592613 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13413322 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/413322
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors Mar 5, 2012 Issued
Array ( [id] => 8265924 [patent_doc_number] => 20120165351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'QUINAZOLINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/410448 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74476 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13410448 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/410448
QUINAZOLINE DERIVATIVES Mar 1, 2012 Abandoned
Array ( [id] => 8265901 [patent_doc_number] => 20120165341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'THERAPEUTIC AGENT FOR SENILE DEMENTIA' [patent_app_type] => utility [patent_app_number] => 13/409075 [patent_app_country] => US [patent_app_date] => 2012-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4045 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13409075 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/409075
Therapeutic agent for senile dementia Feb 28, 2012 Issued
Array ( [id] => 8251906 [patent_doc_number] => 20120156219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/402033 [patent_app_country] => US [patent_app_date] => 2012-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 117558 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156219.pdf [firstpage_image] =>[orig_patent_app_number] => 13402033 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/402033
NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF Feb 21, 2012 Abandoned
Menu